Literature DB >> 16774289

Methodological aspects in the assessment of treatment effects in observational health outcomes studies.

Josep Maria Haro1, Stathis Kontodimas, Miguel Angel Negrin, Mark Ratcliffe, David Suarez, Frank Windmeijer.   

Abstract

Prospective observational studies, which provide information on the effectiveness of interventions in natural settings, may complement results from randomised clinical trials in the evaluation of health technologies. However, observational studies are subject to a number of potential methodological weaknesses, mainly selection and observer bias. This paper reviews and applies various methods to control for selection bias in the estimation of treatment effects and proposes novel ways to assess the presence of observer bias. We also address the issues of estimation and inference in a multilevel setting. We describe and compare the use of regression methods, propensity score matching, fixed-effects models incorporating investigator characteristics, and a multilevel, hierarchical model using Bayesian estimation techniques in the control of selection bias. We also propose to assess the existence of observer bias in observational studies by comparing patient- and investigator-reported outcomes. To illustrate these methods, we have used data from the SOHO (Schizophrenia Outpatient Health Outcomes) study, a large, prospective, observational study of health outcomes associated with the treatment of schizophrenia. The methods used to adjust for differences between treatment groups that could cause selection bias yielded comparable results, reinforcing the validity of the findings. Also, the assessment of observer bias did not show that it existed in the SOHO study. Observational studies, when properly conducted and when using adequate statistical methods, can provide valid information on the evaluation of health technologies.

Entities:  

Mesh:

Year:  2006        PMID: 16774289     DOI: 10.2165/00148365-200605010-00003

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   2.561


  11 in total

1.  The challenge of selection bias and confounding in palliative care research.

Authors:  Helene Starks; Paula Diehr; J Randall Curtis
Journal:  J Palliat Med       Date:  2009-02       Impact factor: 2.947

2.  Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.

Authors:  Diego Novick; Josep Maria Haro; David Suarez; Martin Lambert; Jean-Pierre Lépine; Dieter Naber
Journal:  Psychopharmacology (Berl)       Date:  2007-02-20       Impact factor: 4.530

3.  The impact of hospital-acquired infection on outcome in acute pancreatitis.

Authors:  Bechien U Wu; Richard S Johannes; Stephen Kurtz; Peter A Banks
Journal:  Gastroenterology       Date:  2008-05-28       Impact factor: 22.682

4.  Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: application of statistical approaches to reduce bias in observational comparisons.

Authors:  Lisa M Willoughby; Mark A Schnitzler; Daniel C Brennan; Brett W Pinsky; Nino Dzebisashvili; Paula M Buchanan; Luca Neri; Lisa A Rocca-Rey; Kevin C Abbott; Krista L Lentine
Journal:  Transplantation       Date:  2009-05-27       Impact factor: 4.939

5.  Active management of risk in nulliparous pregnancy at term: association between a higher preventive labor induction rate and improved birth outcomes.

Authors:  James M Nicholson; Morghan H Stenson; Lisa C Kellar; Aaron B Caughey; George A Macones
Journal:  Am J Obstet Gynecol       Date:  2009-01-24       Impact factor: 8.661

6.  The active management of risk in multiparous pregnancy at term: association between a higher preventive labor induction rate and improved birth outcomes.

Authors:  James M Nicholson; Aaron B Caughey; Morghan H Stenson; Peter Cronholm; Lisa Kellar; Ian Bennett; Katie Margo; Joseph Stratton
Journal:  Am J Obstet Gynecol       Date:  2009-03       Impact factor: 8.661

7.  How is disease severity associated with quality of life in psoriasis patients? Evidence from a longitudinal population-based study in Sweden.

Authors:  Kirk Geale; Martin Henriksson; Marcus Schmitt-Egenolf
Journal:  Health Qual Life Outcomes       Date:  2017-07-28       Impact factor: 3.186

8.  Methodological issues in assessing changes in costs pre- and post-medication switch: a schizophrenia study example.

Authors:  Douglas E Faries; Allen W Nyhuis; Haya Ascher-Svanum
Journal:  Cost Eff Resour Alloc       Date:  2009-05-27

9.  Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the Worldwide Schizophrenia Outpatients Health Outcomes (W-SOHO) study.

Authors:  Jihyung Hong; Diego Novick; Roberto Brugnoli; Jamie Karagianis; Martin Dossenbach; Josep Maria Haro
Journal:  BMC Psychiatry       Date:  2012-12-04       Impact factor: 3.630

10.  Depression, prevalence and some risk factors in elderly nursing homes in tehran, iran.

Authors:  Lyly Nazemi; Ingmar Skoog; Ingvar Karlsson; Saeed Hosseini; Mostafa Hosseini; Mohammad Javad Hosseinzadeh; Mohammad Reza Mohammadi; Zahra Pouransari; Maryam Chamari; Masoud Baikpour
Journal:  Iran J Public Health       Date:  2013-06-01       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.